Tukysa 150 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FSGDV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,698
Award facts
- Contract value 100% obligated
- $47,697.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of TUKYSA 150 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $47,697.60 with firm fixed pricing and an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA (tucatinib) is an oral tyrosine kinase inhibitor used in cancer treatment, reflecting the breadth of pharmaceutical products supplied through the Defense Logistics Agency's medical procurement channels.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, specialty drugs, vaccines, and medical supplies to support military healthcare systems worldwide. The company's portfolio of federal contracts demonstrates its established capability to fulfill diverse medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations through competitively awarded contracts with consistent firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DB25FSGDV?
SPE2DB25FSGDV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FSGDV worth?
The government has obligated $47,698 on SPE2DB25FSGDV.
Is contract SPE2DB25FSGDV an order under another contract?
Yes. SPE2DB25FSGDV is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSGDV competed?
The extent of competition for SPE2DB25FSGDV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award